Literature DB >> 20709372

Does previous robot-assisted radical prostatectomy experience affect outcomes at robot-assisted radical cystectomy? Results from the International Robotic Cystectomy Consortium.

Matthew H Hayn1, Nicholas J Hellenthal, Abid Hussain, Paul E Andrews, Paul Carpentier, Erik Castle, Prokar Dasgupta, Rodney Davis, Raju Thomas, Shamim Khan, Adam Kibel, Hyung Kim, Murugesan Manoharan, Mani Menon, Alex Mottrie, David Ornstein, James Peabody, Raj Pruthi, Joan Palou Redorta, Manish Vira, Francis Schanne, Hans Stricker, Peter Wiklund, Greg Wilding, Khurshid A Guru.   

Abstract

OBJECTIVES: To evaluate the effect of previous robot-assisted radical prostatectomy (RARP) case volume on the outcomes of robot-assisted radical cystectomy. Little is known regarding the effect of previous robotic surgical experience on the implementation and execution of robot-assisted radical cystectomy.
METHODS: Using the International Robotic Cystectomy Consortium database, 496 patients were identified who had undergone robot-assisted radical cystectomy by 21 surgeons at 14 institutions from 2003 to 2009. The surgeons were divided into 4 groups according to their previous RARP experience (≤ 50, 51-100, 101-150, and > 150 cases). The overall operative time, blood loss, lymph node yield, pathologic stage, and surgical margin status were compared among the 4 groups using chi-square analysis.
RESULTS: The mean operative time was 386 minutes (range 178-827). The mean estimated blood loss was 408 mL (range 25-3500). The operative time and blood loss were both significantly associated with previous RARP experience (P < .001). The mean lymph node count was 17.8 nodes (range 0-68). Lymph node yield and increased pathologic stage were significantly associated with previous RARP experience (P < .001). Finally, 34 (7.0%) of the 482 patients had a positive surgical margin. Margin status was not significantly associated with previous RARP experience (P = .089).
CONCLUSIONS: Previous RARP case volume might affect the operative time, blood loss, and lymph node yield at robot-assisted radical cystectomy. In addition, surgeons with increased RARP experience operated on patients with more advanced tumors. Previous RARP experience, however, did not appear to affect the surgical margin status.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20709372     DOI: 10.1016/j.urology.2010.05.010

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

Review 1.  Current status and outcomes of robot-assisted laparoscopic radical cystectomy and urinary diversion.

Authors:  Kyle A Richards; Ashok K Hemal
Journal:  Curr Urol Rep       Date:  2011-04       Impact factor: 3.092

Review 2.  Current status of robot-assisted radical cystectomy for bladder cancer.

Authors:  Faris Azzouni
Journal:  Nat Rev Urol       Date:  2012-07-31       Impact factor: 14.432

3.  Robotic assisted radical cystectomy: insights on long term oncological outcomes from the International Robotic Cystectomy Consortium.

Authors:  Maria Chiara Sighinolfi; Salvatore Micali; Ahmed Eissa; Stefano Carlo Maria Picozzi; Stefano Puliatti; Bernardo Rocco
Journal:  Transl Androl Urol       Date:  2019-12

4.  Early oncologic outcomes of robotic vs. open radical cystectomy for urothelial cancer.

Authors:  Kenneth G Nepple; Seth A Strope; Robert L Grubb; Adam S Kibel
Journal:  Urol Oncol       Date:  2011-07-30       Impact factor: 3.498

Review 5.  Current Status of Robot-Assisted Radical Cystectomy: What is the Real Benefit?

Authors:  Atsushi Takenaka
Journal:  Yonago Acta Med       Date:  2015-10-14       Impact factor: 1.641

Review 6.  Robot-assisted laparoscopic radical cystectomy with complete intracorporeal urinary diversion.

Authors:  Jason M Sandberg; Ashok K Hemal
Journal:  Asian J Urol       Date:  2016-05-27

7.  International Robotic Radical Cystectomy Consortium: A way forward.

Authors:  Syed Johar Raza; Erinn Field; Adam S Kibel; Alex Mottrie; Alon Z Weizer; Andrew Wagner; Ashok K Hemal; Douglas S Scherr; Francis Schanne; Franco Gaboardi; Guan Wu; James O Peabody; Jihad Koauk; Joan Palou Redorta; John G Pattaras; Koon-Ho Rha; Lee Richstone; M Derya Balbay; Mani Menon; Mathew Hayn; Micheal Stoeckle; Peter Wiklund; Prokar Dasgupta; Raj Pruthi; Reza Ghavamian; Shamim Khan; Stephan Siemer; Thomas Maatman; Timothy Wilson; Vassilis Poulakis; Greg Wilding; Khurshid A Guru
Journal:  Indian J Urol       Date:  2014-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.